Needham Reiterates Buy Rating on RxSight, Inc. (RXST)

Market Context

RxSight, Inc. operates in the Healthcare sector. The stock currently trades at $5.60 with a market capitalization of $539.0M. The stock has declined 57.3% over the past 52 weeks.

Analyst coverage from Needham provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for RxSight, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for RxSight, Inc.

Among the 10 most recent ratings: 3 Buy, 6 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jul 07, 2026	Needham	Buy	N/A
May 07, 2026	Wells Fargo	Equal-Weight	N/A
May 07, 2026	Needham	Buy	N/A
Mar 09, 2026	Stifel	Hold	N/A
Feb 26, 2026	Piper Sandler	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View RXST Stock Page